RGH-188, an atypical antipsychotic with dopamine D3/D2 antagonist/partial agonist properties:: In vitro characterisation

被引：0
|
作者：
Kiss, B. [1 ]
Laszlovszky, I. [1 ]
Horvath, A. [1 ]
Schmidt, E. [1 ]
Bugovics, Gy. [1 ]
Orosz, Sz. [1 ]
Hornok, K. [1 ]
Gyertyan, I. [1 ]
Agai-Csongor, E. [1 ]
Domany, Gy. [1 ]
Tihanyi, K. [1 ]
Szombathelyi, Zs. [1 ]
机构：
[1] G Richter Ltd, Budapest, Hungary
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2006年 / 9卷
关键词：
D-3 RECEPTOR ANTAGONIST;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S221 / S222
页数：2
相关论文
共 50 条
  • [41] Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor
    Wood, MD
    Boyfield, I
    Nash, DJ
    Jewitt, FR
    Avenell, KY
    Riley, GJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 407 (1-2) : 47 - 51
  • [42] CARIPRAZINE, A D3-PREFERRING DOPAMINE D3/D2 RECEPTOR PARTIAL AGONIST ANTIPSYCHOTIC CANDIDATE DEMONSTRATES ANTI-ABUSE POTENTIAL IN RATS
    Gyertyan, Istvan
    Roman, V.
    Saghy, K.
    Kiss, B.
    Szombathelyi, Z.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 288 - 289
  • [43] I-chloroscoulerine mesylate -: Antipsychotic dopamine D1 agonist/D2 antagonist
    Li, Jianfeng
    Jin, Guozhang
    Shen, Jingshan
    Shanghai, Ruyun A.
    DRUGS OF THE FUTURE, 2006, 31 (05) : 379 - 384
  • [44] Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug
    Jin Mizushima
    Keisuke Takahata
    Noriko Kawashima
    Motoichiro Kato
    Annals of General Psychiatry, 11
  • [45] Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug
    Mizushima, Jin
    Takahata, Keisuke
    Kawashima, Noriko
    Kato, Motoichiro
    ANNALS OF GENERAL PSYCHIATRY, 2012, 11
  • [46] Antipsychotic regulation of dopamine D1, D2 and D3 receptor mRNA
    D'Souza, U
    McGuffin, P
    Buckland, PR
    NEUROPHARMACOLOGY, 1997, 36 (11-12) : 1689 - 1696
  • [47] Transformation of a Dopamine D2 Receptor Agonist to Partial Agonists as Novel Antipsychotic Agents
    Liu, Ruiquan
    Qi, Jianzhong
    Wang, Huan
    Fan, Luyu
    Zhang, Pei
    Yu, Jing
    Tan, Liang
    Wang, Sheng
    Cheng, Jianjun
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (09) : 6274 - 6287
  • [48] Aripiprazole, a novel antipsychotic, is a potent partial agonist at human dopamine D2 receptors
    Burris, KD
    Molski, TF
    Ryan, E
    Xu, C
    Tottori, K
    Kikuchi, T
    Yocca, FD
    Molinoff, PB
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 88 - 88
  • [49] Non-selective D3/D2 antagonist but not a selective D3 antagonist is active in rodent models predictive of antipsychotic activity
    Lesage, Anne
    Pouzet, Bruno
    Megens, Anton
    Macdonald, Gregor
    Markou, Athina
    Langlois, Xavier
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S112 - S112
  • [50] Functionally Selective Dopamine D2, D3 Receptor Partial Agonists
    Moeller, Dorothee
    Kling, Ralf C.
    Skultety, Marika
    Leuner, Kristina
    Huebner, Harald
    Gmeiner, Peter
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (11) : 4861 - 4875
12345